Lucid Diagnostics Inc. Common Stock

LUCDNASDAQUSD
1.13 USD
0.01 (0.88%)AT CLOSE (11:59 AM EDT)
1.13
0.01 (0.44%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
1.13
0.01 (0.44%)
🟢Market: OPEN
Open?$1.13
High?$1.15
Low?$1.12
Prev. Close?$1.14
Volume?262.3K
Avg. Volume?671.7K
VWAP?$1.14
Rel. Volume?0.39x
Bid / Ask
Bid?$0.97 × 100
Ask?$1.30 × 100
Spread?$0.33
Midpoint?$1.14
Valuation & Ratios
Market Cap?194.2M
Shares Out?176.9M
Float?88.5M
Float %?64.5%
P/E Ratio?N/A
P/B Ratio?17.76
EPS?-$0.41
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.31Adequate
Quick Ratio?1.30Adequate
Cash Ratio?1.21Strong
Debt/Equity?2.19High
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
17.76HIGH
P/S?
41.27HIGH
P/FCF?
N/A
EV/EBITDA?
-3.8CHEAP
EV/Sales?
38.99HIGH
Returns & Efficiency
ROE?
-645.3%WEAK
ROA?
-174.5%WEAK
Cash Flow & Enterprise
FCF?$-46682000
Enterprise Value?$183.5M
Related Companies
Loading...
News
Profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Employees
82
Market Cap
194.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-10-14
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: 212 949 4319